Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Protocols|August 4, 2022
Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood CellsKayluz Frias Boligan, Gurleen Sandhu, Donald R Branch
Cellular and Molecular Life Sciences : CMLS|December 10, 2014
Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defenseKayluz Frias Boligan, Circe Mesa, Luis Enrique Fernandez, et al.
Frontiers in Immunology|October 10, 2022
(NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosusRuqayyah J Almizraq, Kayluz Frias Boligan, Melika Loriamini, et al.
Molecules (Basel, Switzerland)|January 21, 2023
Small Molecule Drugs That Inhibit PhagocytosisMelika Loriamini, Melissa M Lewis-Bakker, Kayluz Frias Boligan, et al.
Transfusion|February 7, 2026
IgG4 anti-CD47: Erythrophagocytosis and potential transfusion complicationsKayluz Frias Boligan, Melika Loriamini, Mairead B Holton, et al.
Journal of Cellular Physiology|May 30, 2020
Arginase-II promotes melanoma migration and adhesion through enhancing hydrogen peroxide production and STAT3 signalingYi Yu, Diogo Ladeiras, Yuyan Xiong, et al.
The Journal of Allergy and Clinical Immunology|December 14, 2020
Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine modelPaul Engeroff, Kevin Plattner, Federico Storni, et al.
International Journal of Molecular Sciences|February 13, 2026
Recombinant Human IgG1-Hexamer Reduces Pathogenic Autoantibodies in the K/BxN Mouse Model of Arthritis Independent of FcRnBonnie J B Lewis, Ruqayyah J Almizraq, Selena Cen, et al.
Pharmacology|January 25, 2023
Modulation of Neutrophil Function by Recombinant Human IgG1 Fc Hexamer in the Endogenous K/BxN Mouse Model of Rheumatoid ArthritisRuqayyah J Almizraq, Kayluz Frias Boligan, Bonnie J B Lewis, et al.
Pageof 2